André Zimerman
@andrezimerman.bsky.social
Cardiologist, MD, PhD | Head, Clinical Trials Unit (ARO), Hosp. Moinhos de Vento 🇧🇷 | Professor, Postgrad Cardiology, UFRGS 🇧🇷 | Fellowship, TIMI Study Group, BWH/HMS 🇺🇸 | Lipids, Trials, Cardiology
"Does lowering LDL-C to very low levels result in long-term cognitive impairment?" 🧠🫀
I've heard this question many times.
Now we have long-term data.
A 🧵 on our new NEJM Evidence paper: evidence.nejm.org/doi/full/10....
I've heard this question many times.
Now we have long-term data.
A 🧵 on our new NEJM Evidence paper: evidence.nejm.org/doi/full/10....
December 26, 2024 at 11:26 PM
"Does lowering LDL-C to very low levels result in long-term cognitive impairment?" 🧠🫀
I've heard this question many times.
Now we have long-term data.
A 🧵 on our new NEJM Evidence paper: evidence.nejm.org/doi/full/10....
I've heard this question many times.
Now we have long-term data.
A 🧵 on our new NEJM Evidence paper: evidence.nejm.org/doi/full/10....
Thank you #CVCTForum for the opportunity to talk about clinical trials in LATAM.
Exciting time for global cardiovascular trials 🌎
Exciting time for global cardiovascular trials 🌎
December 11, 2024 at 11:00 PM
Thank you #CVCTForum for the opportunity to talk about clinical trials in LATAM.
Exciting time for global cardiovascular trials 🌎
Exciting time for global cardiovascular trials 🌎